期刊文献+

扎鲁司特的合成工艺改进 被引量:1

Improved Synthetic Procedure of Zafirlukast
原文传递
导出
摘要 目的合成扎鲁司特,改进工艺。方法5-硝基-1H-吲哚经甲基化、付-克反应、缩合、还原和酰胺化反应制得扎鲁司特,主要对甲基化、付-克反应和还原工艺进行了改进。结果通过优化条件合成了扎鲁司特,总收率31.6%,目标化合物结构经红外、质谱、核磁共振谱、元素分析确证。结论改进后的工艺原材料价廉易得,降低了生产成本,更适合工业化生产。 OBJECTIVE To improve the synthetic procedure of zafirlukast. METHODS Zafirlukast was synthesized from 5- nitro-lH-indole via methylation, alkylation, condensation, reduction and acylation. The methylation, alkylation and reduction are key steps in the procedure. RESULTS Zafirlukast was prepared in an overall yield of 31.6%. The structure of the target compound was confirmed by IR spectra, MS, H-NMR and elemental analysis. CONCLUSION The improved procedure avoids the use of expensive reagents and the target compound was synthesized in a convenient way. The method is suitable for industrial manufacture.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2009年第1期36-38,共3页 Chinese Journal of Modern Applied Pharmacy
关键词 工艺改进 甲基化 还原 扎鲁司特 improved synthetic procedure methylation reduction zafirlukast
  • 相关文献

参考文献6

  • 1HOGABOOM G K,MONG S,WU H L,et al. Peptidoleukotrienes:distinct receptors for leukotriene C4 and 134 in the guinea-pig lung [ J ]. Biochem Biophys Res Commun, 1983,116 ( 3 ) : 1136.
  • 2李伟,宁奇.扎鲁司特的合成[J].中国医药工业杂志,2004,35(8):451-452. 被引量:3
  • 3Srinivas K,Srinivasan V,KRISHNA M R,et al. A Novel and Efficient Route to Zafirlukast [ J ]. Org Process Res Dev, 2004, 8 (16) :952-954.
  • 4BROWN F J,BERNSTEIN P R,YEE Y K,et al. Heterocyclic amide derivatives : US :4859692, [ P]. 1989-08-22.
  • 5ARIE G, GENNDY N, LGOLGOR Z, et al. Process for the preparation of Zafirlukast :WO,02/46153 A2 [ P]. 2002-06-13.
  • 6MARASSA V G, MADUSKUIE,SHAPIRO HS, et al. Evolution of a Series of Peptidoleukotriene Antagonists: Synthesis and Structure/Activity Relationships of 1, 3,5-Substitued Indoles and Indazoles. [J]. J Med Chem,1990,33:1781-1790.

二级参考文献2

  • 1Finnerty JP, Wood B, Thomson HH, et al. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of IC I204219, a potent leukotirinene D4 receptor antagonist [J]. Am Rev Respir Dis, 1992, 145(4 Pt 1):746-749.
  • 2Brown FJ, Bemstein PR, Yee YK, et al. Heterocyclic amide derivatives[P]. US: 4859692, 1989-08-22. (CA 1987, 106:176163b)

共引文献2

同被引文献11

  • 1李伟,宁奇.扎鲁司特的合成[J].中国医药工业杂志,2004,35(8):451-452. 被引量:3
  • 2Srinivas K,,Srinivasan N,Krishna MR,et al.A noval andeffi cient route to zafi rlukast. Organic Process Research and Development . 2004
  • 3Manne SR,Muppa KK,Keesari S,et al.An improvedprocess for the preparation of zafi rlukast. IN,2002MA00992 . 2007
  • 4Brown FJ,Bemstein PR,Yee YK,et al.Heterocyclic amidederivatives. US,4859692 . 1989
  • 5Ancall CL,Derrick I,Moseley JD,et al.Investigation intothe acidification process of zafirlukast nitroacid lead to asurprising improvement in product quality. Org ProcessRes Dev . 2004
  • 6Goverdhan G,Reddy AR,Sampath A,et al.An improvedand scalable process for zafi rlukast:an asthma drug. OrgProcess Res Dev . 2009
  • 7Goverdhan G,Reddy AR,Srinivas K,et al.Identification,characterization and synthesis of impurities of zaf irlukast. Journal of Pharmaceutical and Biomedical Analysis . 2009
  • 8Grant TG,Sarashar S.Substituted indoles as cysteinylleukotriene receptor modulators and their preparaon anduse in the treatment of disease. WO,2009018280 . 2009
  • 9Sally E. Wenzel MD.New Approaches to Anti-Inflammatory Therapy for Asthma. The American Journal of Medicine . 1998
  • 10Z Diamant,EH Bel,PN Dekhuijzen.Anti-leukotriene therapy in asthma. Netherlands Journal of Medicine . 1998

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部